|
Indianapolis, Ind. October 27, 2004
Roche Diagnostics Awarded Blood Glucose and Lancet Contracts by
HealthTrust Purchasing Group
Blood glucose agreement broadens access
to actionable healthcare information available from Point of Care
testing; Lancet agreement brings comfort and safety to patients
and staff
Roche Diagnostics announced today that the company has signed a
new dual source three-year contract with HealthTrust Purchasing
Group (HPG) LLC to provide hospital glucose meters, test strips,
and ancillary connectivity solutions to HPG members. The blood glucose
contract is effective September 1, 2004 through August 31, 2007.
In addition, a separate optional source contract for the ACCU-CHEK®
Safe-T-Pro® Lancet devices has also been signed and is effective
through April 31, 2006.
Included under these contracts are the ACCU-CHEK Inform hospital
blood glucose monitor, the ACCU-CHEK Comfort Curve Hospital Test
Strips, , the ACCU-CHEK Safe-T-Pro Lancet Device, and ACCU-CHEK
Safe-T-Pro Plus Lancet Device and ancillary IT products, including
Medical Automation Systems' RALS® products.
"Our new contracts continue a long-term relationship with
HPG. The contracts for blood glucose and lancets complement each
other and provide our complete portfolio of hospital glucose products
to HPG members," said Rod Cotton, Vice President, Sales &
Marketing, Roche Diagnostics Diabetes Care Hospital Group "With
the incidence of diabetes dramatically increasing in the United
States, healthcare professionals need the tools that can help them
streamline their information and offer efficiency and safety in
their testing. The connectivity functions of our Accu-Chek products
as well as the breadth of our blood glucose product portfolio answer
their needs."
HealthTrust Purchasing Group, LP (HPG) is a healthcare group purchasing
organization. Established in May 1999, they are committed to superior
patient care delivered through national contracts negotiated with
market-leading suppliers at competitive prices. More information
about HPG is available at www.healthtrustpg.com.
About Roche and the Roche Diagnostics
Division
Headquartered in Basel, Switzerland, Roche is one of the world's
leading research-intensive healthcare groups. Its core businesses
are pharmaceuticals and diagnostics. As a supplier of innovative
products and services for the prevention, diagnosis and treatment
of disease, the Group contributes on a broad range of fronts to
improving people's health and quality of life. Roche is number one
in the global diagnostics market, the leading supplier of medicines
for cancer and transplantation and a market leader in virology.
In 2003, the Pharmaceuticals Division generated 19.8 billion Swiss
francs in prescription drug sales, while the Diagnostics Division
posted sales of 7.4 billion Swiss francs. Roche employs roughly
65,000 people in 150 countries and has R&D agreements and strategic
alliances with numerous partners, including majority ownership interests
in Genentech and Chugai.
Roche's Diagnostics Division, the world leader in in-vitro diagnostics
with a uniquely broad product portfolio, supplies a wide array of
innovative testing products and services to researchers, physicians,
patients, hospitals and laboratories world-wide. Roche Diagnostics'
North American headquarters are located in Indianapolis, Ind. (www.roche-diagnostics.us).
For further information, please visit www.roche.com
and www.roche-diagnostics.com.
ACCU-CHEK, Comfort Curve, Safe-T-Pro, and ACCU-CHEK Inform are trademarks
of a Member of the Roche Group.
RALS is a trademark of Medical Automation Systems
For additional information contact:
Lori LeRoy
Roche Diagnostics
Tel.: +1-317-521-7159
e-mail: lori.leroy@roche.com
www.roche-diagnostics.us
|
